Through the downstream JAK‐STAT signaling pathway, METTL3 lactylation promotes the expression of immunosuppressive effector molecules such as interleukin (IL‐6, IL‐10, and inducible nitric oxide synthase), ultimately promoting tumor immune evasion and accelerating tumor growth and proliferation [64]. Here, METTL3 is linked to neoplasm.